Eleven monoclonal antibodies (MAbs) specific for P1, the major protein surface antigen of Streptococcus mutans serotype c, were characterized by Western blot (immunoblot) analysis and by radioimmunoassay using whole bacterial cells. The approximate binding domains of the MAbs were determined by using full-length and truncated P1 polypeptides. The accessibility of these binding sites on the surfaces of intact bacteria was determined by radioimmunoassay. The ability of each MAb to cross-react with related proteins from strains of S. mutans serotypes e and f, S. sanguis, and S. sobrinus serotype g is also reported.
Mutans streptococci are present in large numbers in dental plaque. There is a strong correlation between the presence of these organisms in plaque and the occurrence of dental caries in humans (22, 38) . A number of species make up the group of mutans streptococci, including Streptococcus mutans (serotypes c, e, and f), S. sobrinus (serotypes d and g), S. cricetus (serotype a), S. rattus (serotype b), S. macacae (serotype h), and S. downei (serotype h) (4, 8, 9, 52, 61) . These species are distinguished by differences in the guanine and cytosine content of their DNA, sugar fermentation, bacitracin sensitivity, colony morphology on sucrose-containing media, and cell protein profiles obtained by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. All species of mutans streptococci except S. rattus express a high-molecular-weight surface protein which is believed to function as an adhesin enabling the organisms to bind to the salivary pellicle or other plaque microorganisms on tooth surfaces (16, 19, 29, 30, 34, 41, 55) . This 185,000-Mr protein was first identified on S. mutans serotype c strains and has been referred to by various investigators as P1 (3, 18, 28, 33, 34) , antigen B (50, 51) , I/II (49, 62) , IF (24) , PAc (45, 46, 57) , and MSL-1 (13) . We will use the designation P1 in this article. Immunologically cross-reactive proteins have been designated antigen SR (2) (Mr = 74,000) for S. mutans serotype f strains, SpaA (1, 10, 20, 23) and PAg (44, 57) (Mr = 210,000) for S. sobrinus serotype d and g strains, and SSP-5 (11, 12) (Mr = 205,000) for S. sanguis strains.
A number of genes encoding the related oral streptococcal surface adhesin proteins have been cloned and sequenced. The genes include spaP (26, 33) , pac (45, 46) , and MSL-1 (13) from S. mutans serotype c; sr (43, 54) from S. mutans serotype f; spaA (23, 32, 56) and pag (57) from S. sobrinus serotype g; and SSP-5 (11, 12) from S. sanguis. Primary amino acid sequences predicted on the basis of nucleic acid sequences demonstrate high but variable degrees of homology among these antigenically related proteins (32) . In addition to the level of homology with one another at the primary sequence level, all of the proteins demonstrate highly conserved common structural features. All possess an amino-terminal leader sequence which is removed by posttranslational processing. The amino-terminal third of each of * Corresponding author. the molecules contains a series of alanine-rich tandem repeat sequences predicted to result in an alpha-helical structure typical of coiled-coil proteins. All of these proteins also have a series of proline-rich tandem repeat sequences in the central region of the molecules predicted to result in a structure exhibiting many beta turns. In addition, the proteins all possess a second proline-rich sequence at their carboxy termini which is similar to that described for other streptococcal surface proteins and is believed to span the cell wall (17) . All but SSP-5 demonstrate a conserved carboxy-terminal consensus sequence, L-P-X-T-G, which was first identified for M protein and is common to a number of streptococcal surface antigens. This sequence is believed to serve as a signal for the posttranslational modification of proteins whereby they are cleaved by a thiol-dependent membrane anchor-cleaving enzyme and subsequently attached to a putative cell membrane anchor molecule (48) .
There has been considerable interest in using P1 as an immunogen to protect against dental caries (25, 35, 37) . In addition, several researchers have reported promising results using anti-Pl antibodies to protect against S. mutans colonization in passive immunization studies (36, 39, 40, 47) . Characterization of the interaction of P1 with anti-Pl antibodies will be useful in determining the immunogenic regions of the protein as well as understanding the mechanism of protection observed with certain anti-Pl antibodies. The goal of this study was to characterize our panel of monoclonal antibodies (MAbs) prepared against antigen P1 (3). The approximate locations of reactivity of 11 MAbs were determined by Western blot (immunoblot) analysis using fulllength and truncated P1 polypeptides. A radioimmunoassay (RIA) was used to determine the accessibility of epitopes to each of the MAbs on the surface of intact S. mutans serotype c bacterial cells. In addition, the ability of the MAbs to cross-react with the P1 molecule from a serotype e isolate and with antigens SR, SpaA, and SSP-5 was determined by Western blot analysis and by whole-cell RIA. The results of this study have allowed these MAbs to be used as tools for understanding the interaction between P1 and salivary com-anti-Pi MAbs to be added to those MAbs already available to differentiate between different species of mutans streptococci (14, 15 anti-Pl MAbs were generated as described previously (3).
Murine hybridoma ascitic fluids served as a source of MAbs. Briefly, the ascitic fluids were prepared as follows. Stable antibody-producing hybridoma lines were retrieved from storage as frozen suspensions in liquid nitrogen (in 10% dimethyl sulfoxide) and grown to confluence at 37°C in 8% CO2 in RPMI 1640 medium supplemented with L-glutamine (2 mM), penicillin (50,000 IU/liter), streptomycin (50,000 ,ug/liter), and HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (5 mM) (Media Tech, Washington, D.C.) containing 10% fetal bovine serum (Flow Laboratories, McLean, Va.). The cells from one 250-mI, 75-cm2 polystyrene bent-neck culture flask (Miles Laboratories, Inc., Naperville, Ill.) were resuspended in a mixture of 2 ml of RPMI 1640 medium and 1 ml of phosphate-buffered saline (PBS) pH 7.2, and injected into six mice intraperitoneally (0.5 ml of hybridoma suspension per mouse). The mice were monitored for development of ascitic fluid. Approximately 3 to 4 ml of ascitic fluid could be harvested per mouse approximately 3 to 4 weeks after injection, depending on the hybridoma used. Ascitic fluids were clarified after collection by centrifugation at 10,000 x g for 10 min and stored at -200C. Precipitation of bacterial proteins from culture supernatant. Cells were removed from a 1-liter overnight TDM culture of strain NG5 by centrifugation, and the supernatant was filtered through a 0.2-,u.m-pore-size Nalgene Disposable Filterware unit (Nalge Co., Rochester, N.Y.). Proteins were precipitated by the addition of ammonium sulfate (Fisher Scientific, Fair Lawn, N.J.) to 65% saturation for 48 h at 40C. Precipitated proteins were removed by centrifugation at 15,000 x g for 5 h at 4°C, and the pellet was resuspended in 2 ml of PBS. The resuspended proteins were dialyzed for 48 h at 40C against 4 liters of PBS with two changes of medium.
Phosphate buffer extraction of mutans streptococci. Bacterial cells from 1-liter overnight TDM cultures of strains NG8, V100, OMZ175, 834, and 6715 were harvested by centrifugation at 10,000 x g for 30 min at 4°C, washed once with 100 ml of PBS, and resuspended in 3 ml of 0.5 M phosphate buffer, pH 6.0, as described previously (53 (31) . Proteins were electroblotted onto nitrocellulose membranes for 3 h at 70 V by the method of Towbin et al. (60) . To reduce nonspecific antibody binding, membranes were washed with PBS containing 0.25% gelatin and 0.25% Tween 20 (PBS-Gel-Tw), with four changes of medium, for 15 anti-mouse immunoglobulin G (IgG) (Cappel, Organon Teknika Corp., West Chester, Pa.) diluted in PBS-Gel-Tw. Next, the blot strips were washed twice (15 min each time) with 5 ml of PBS-Gel-Tw and twice (15 Two-stage RIA of intact bacterial cells. A two-stage RIA (7) was used to determine the reactivity of anti-Pl MAbs with P1 or P1-like molecules on the surface of intact bacterial cells. Bacteria were harvested from 25-ml TDM overnight cultures by centrifugation at 2,000 x g for 10 min, and the cells were resuspended in 5 ml of PBS (pH 7.2). These suspensions were found routinely to correspond to readings of 400 Klett units (Klett-Summerson photoelectric colorimeter; Klett Manufacturing Co., Inc., Long Island City, N.Y.). Tubes containing 100 RI of bacterial suspension were incubated for 1 h at 37°C with 100 ,ul of 1:500 dilutions of each anti-Pl mouse hybridoma ascitic fluid in PBS-Gel-Tw to reduce nonspecific binding. Serial titration of all ascitic fluids was performed first to ensure that the dilution used contained antibody in excess and that observed differences in ability to bind bacterial cells were not merely a reflection of differences in titer. Anti-Actinobacillus actinomycetemcomitans mouse hybridbma ascitic fluid was included in each assay as a negative control to indicate nonspecific binding of immunoglobulins. After incubation, the cells were washed once with 2 ml of PBS to remove unbound antibodies and pelleted by centrifugation at 2,000 x g for 10 min, and the supernatants were decanted. The cell pellets were resuspended in residual buffer (-100 ,ul) by vortexing. Bacterially bound antibody was quantitated by incubating the cell suspension for 1 h at 37°C with 100 ,ul of 125I-radiolabeled sheep anti-mouse IgG (Amersham Corp., Arlington Heights, Ill.) containing approximately 30,000 cpm in PBS-Gel-Tw.
After incubation, the cells were washed twice with 2 ml of PBS-Gel-Tw containing 0.01 M EDTA to remove any label not associated with a bacterial antigen-antibody complex. The bacterium-associated radioactivity was measured in a Beckman 5500 auto-gamma counter (Beckman Instruments, Palo Alto, Calif.). The background level of radioactivity was determined with control tubes containing bacteria and 12511
sheep anti-mouse IgG only. All assays were performed in triplicate.
RESULTS
Reactivity of anti-Pl MAbs with S. mutans serotype c, e, and f P1 proteins. Eleven anti-Pl MAbs were tested for their reactivity by Western blot analysis against P1 and P1-like proteins isolated by phosphate buffer extraction from S. mutans NG8, V100, and OMZ175 (Fig. 1) . These strains represent serotype c, e, and f isolates, respectively (Fig. 1A , B, and C, respectively). All anti-Pi MAbs (lanes 1 to 11) demonstrated reactivity, to greater or lesser extents, with a major high-molecular-weight protein band with an Mr of 185,000 from all three serotypes. In addition to demonstrating weak reactivity with the full-length protein from all three serotypes, anti-Pl MAb 3-8D2a (lane 1) also reacted with a number of lower-molecular-weight polypeptide bands. These are thought to represent breakdown products of the parent molecules, since P1 preparations have been reported to undergo proteolytic degradation (18, 28) . Anti-Pl MAb 1-6F6b (lane 11) reacted very weakly with the 185,000-Mr protein isolated from all three serotypes by this procedure. An anti-A. actinomycetemcomitans MAb used as a negative control (lane 12) was not reactive with proteins from the serotype c and e strains ( Fig. 1A and B) but did cross-react with the protein isolated from the serotype f strain (Fig. 1C) . The results of the Western blot reactivities of the anti-Pl MAbs with P1 from serotype c, e, and f isolates of S. mutans are summarized in Table 1 . 
a Reactivity data are from Western blot analysis ( Fig. 1 to 4) . +, reactivity; +, weak reactivity; -, no reactivity. Protein sizes are given in kilodaltons or as amino acid (aa) positions deduced from the spaP gene of NG5 (26) . SM2949 and 26R3 indicate E. coli JM109 harboring pSM2949 and p26R3, respectively. Reactivity of anti-Pl MAbs with full-length and truncated P1 polypeptides. Soluble bacterial proteins were precipitated from the culture supernatant of S. mutans serotype c strain NG5. This strain is a nonretainer in that P1 is primarily released from the cell surface rather than being retained as part of the outer "fuzzy coat" (3, 28) . The mechanism by which retention as opposed to nonretention occurs is unclear. In addition to full-length 185,000-Mr P1 released by NG5, a major 140,000-Mr truncated P1 polypeptide is found (Sa). Knox et al. (28) have shown not only that different strains of S. mutans serotype c demonstrate different quantities of extracellular P1 but that at least three patterns of expression of P1 polypeptides with Mrs <185,000 can be observed. Again, these are presumed to represent breakdown products of the parent P1 molecule (18, 28) . The 11 anti-Pl MAbs were tested for their reactivity with 185,000-and 140,000-Mr P1 polypeptides and lower-molecular-weight P1 polypeptides present in NG5 culture supernatants by Western blot analysis ( Fig. 2A) . In general, much stronger reactivities were observed with ammonium sulfate-precipitated antigen from NG5 than with the antigen present in the phosphate buffer extract of NG8 (compare Fig. 1A and 2A) . Several patterns of reactivity with the NG5 polypeptides were observed. For example, MAbs 6-llA3a (Fig. 2A, 2B, lane 7) , the reactivities of MAbs with recombinant 150,000-Mr P1 paralleled their reactivities with NG5 140,000-Mr P1.
Three of the eleven anti-Pl MAbs reacted with polypeptides isolated from a P1-deficient mutant designated 834 (Fig.  2C ). This strain was derived by allelic exchange of the spaP gene in serotype c strain NG8 with an insertionally inactivated recombinant spaP gene fragment (34) . Sequence analysis of the entire gene (26) subsequent to the construction of 834 indicated that the insertion interrupted the gene between bp 1937 and 3345 of spaP. Strain 834 would therefore be capable of expressing the amino-terminal 612 amino acids of P1 immediately prior to the insertional inactivation site. MAb 3-8D2a (Fig. 2C, lane 1 Cross-reactivity of anti-Pl MAbs with SSP-5 and SpaA proteins. The ability of the 11 anti-Pl MAbs to cross-react with the surface adhesin molecules from S. sanguis M5 and S. sobrinus serotype g 6715 also was determined by Western blot analysis (Fig. 4) . MAb 3-8D2a reacted with both SSP-5 and SpaA proteins (lane 1). As had been observed with P1 and SR (Fig. 1, lanes 1) , this MAb reacted more strongly with lower-molecular-weight polypeptides than with the full-length proteins. MAbs 4-10A8C, 5-5D6a, and 5-3E5e were also cross-reactive with both SSP-5 and SpaA proteins (Fig.  4, lanes 2, 3, and 7 ), although differences in the relative intensities of their reactivity with SSP-5 versus SpaA were seen. MAbs 3-lOE4d and 3-3B5e were cross-reactive with SSP-5 but not with SpaA (lanes 6 and 8), while MAb 6-8CIa was cross-reactive with SpaA but not with SSP-5 (lane 10).
MAbs 4-9D4c, 6-11A3a, 2-8Gld, 1-6F6b, and the anti-A. actinomycetemcomitans negative control did not bind to either SSP-5 or SpaA (lanes 4, 5, 9, 11, and 12). These results are summarized in Table 1 .
Reactivity of anti-PI MAbs with S. mutans serotype c intact bacterial cells. In order to determine whether the epitopes recognized by the anti-Pl MAbs are exposed on the surface of intact bacteria, a two-stage RIA was performed. The reactivities of the 11 anti-Pi MAbs were tested by RIA against four strains of S. mutans serotype c, NG8, Ingbritt 175, KPSK2, and MT8148 (Fig. 5) . The amount of 1251_ radiolabeled sheep anti-mouse IgG tracer associated with the bacterial pellets reflects the degree of binding of each MAb to the bacteria in the first stage of the assay. As with Western blot analysis, different degrees of reactivity were evident for each MAb. For example, MAb 1-6F6b, which was only marginally reactive on most Western blots ( Fig. 1 and 2 Reactivity of anti-Pl MAbs with S. mutans serotypes e and f, S. sanguis, and S. sobrinus serotype g intact bacterial cells. In addition to determination of the cross-reactivities of the anti-Pl MAbs by Western blot analysis, intact cells of strains V100 (S. mutans serotype e), OMZ175 (S. mutans serotype f), M5 (S. sanguis), and 6715 (S. sobrinus serotype g) were tested by whole-cell RIA (Fig. 6) . The patterns of reactivity with the S. mutans serotype e (Fig. 6A ) and serotype f (Fig.  6B) strains were nearly identical to that seen with the serotype c strains (compare Fig. 6 with Fig. 5 ). The reactivity profiles of anti-Pi MAbs with whole cells of S. sanguis M5 (Fig. 6C) and S. sobrinus 6715 (Fig. 6D) were similar, but not identical to, their reactivity profiles with SSP-5 and SpaA proteins on Western blots (compare Fig. 6 with Fig. 4 and Table 1 ). In general, as was seen on Western blots, the level of cross-reactivity of anti-Pl MAbs appeared to be lower with SpaA from S. sobrinus 6715 than with SSP-5 from S. sanguis M5. Differences in Western blot and RIA crossreactivity profiles of the anti-Pl MAbs against SSP-5 and SpaA most likely reflect differences between the accessibility of epitopes on denatured proteins and their accessibility on native proteins on whole cells.
Further evidence for immunological variation between P1 and SpaA was obtained by adsorbing polyclonal rabbit anti-Pl antiserum with S. sobrinus 6715 to remove anti-SpaA DISCUSSION A composite of the results of Western blotting experiments using full-length and truncated P1 polypeptides has allowed the locations of the binding sites of the anti-Pi MAbs to be estimated. A schematic diagram of the approximate locations of reactivity of the MAbs in the context of the molecular architecture of P1 is shown in Fig. 7 . Only one MAb, 3-8D2a, reacted with P1 polypeptides encoded by both recombinant p26R3 (amino acids 1 to 480) and mutant strain 834 (amino acids 1 to 612) in which only the amino-terminal portion of the molecule is expressed. This suggests that the cognate epitope for 3-8D2a lies within the first 480 amino acids of the protein (following cleavage of the 38-residue leader sequence). This region includes the series of three tandem 82-residue alanine-rich tandem repeats (A region) predicted on the basis of the nucleotide sequences of spaP and pac. The A-region repeats exhibit a seven-residue periodicity (27) , also demonstrated by other streptococcal surface proteins such as group A streptococcal M protein (17) and pneumococcal PspA (58), which is predicted to result in an alpha-helical coiled-coil structure. Analysis of the predicted secondary structure of P1 with the IBI MacVector software package (data not shown) indicates that the A region does not have a high probability of being exposed on the surface of the molecule, nor does it have a high antigenic index. Goldschmidt and Curtiss (20) have reported that antigenic determinants of the recombinant SpaA protein are distributed along the carboxy-terminal two-thirds of the molecule and are not encoded by the region of the spaA gene specifying the first 56 kDa of the protein. Consistent with these predictions, only one of the eleven MAbs tested, 3-8D2a, was reactive with the amino terminus of P1. This antibody demonstrated unique reactivity on Western blots in that it was at least as reactive, if not more so, with lower-molecular-weight P1 polypeptides as with full-length proteins (Fig. 1, 2 , and 4, lanes 1) and its RIA reactivity with intact bacterial cells also was only moderate (Fig. 5 and 6, bars 1) . Taken together, these results suggest that 3-8D2a recognizes an epitope which is partially masked on full-length native molecules. All P1-like molecules tested, including P1 from S. mutans serotypes e and f, SSP-5, and SpaA, were reactive with 3-8D2a indicating that a conserved epitope lies within the amino-terminal third of this family of proteins.
Five MAbs, 4-10A8:, 5-5D6a, 4-9D4d, 6-11A3a, and 3-lOE4d, mapped to the central region of P1 (Fig. 7) . Two of these MAbs, 4-10A8, and 4-9D4c, reacted with the truncated product of insertionally inactivated mutant 834 but not with that of recombinant p26R3, suggesting that they are at least partially reactive within the region containing amino acids (6) . Secondary structure analysis indicates that, in general, the central region exhibits a higher antigenic index than does the region consisting of first 480 residues of P1 and that the P region in particular has a high surface probability score. Indeed, all of these five MAbs demonstrated significant reactivity with intact S. mutans cells when tested by RIA, indicating that their binding sites are well exposed when P1 is in its native configuration on the cell surface ( Fig. 5 and 6 , bars 2 to 6). The ability of certain MAbs to react to a greater extent than others with P1 in its native configuration on the surface of intact cells may reflect the accessibility of epitopes as a result of the conformation of the P1 protein itself. Alternatively, some epitopes may be buried or masked by adjacent surface structures other than P1.
Four MAbs, 5-3E5e, 3-3B5e, 2-8G1d, and 6-8Cla mapped to the carboxy terminus of P1 (Fig. 7) . These four MAbs demonstrated the common property of decreased whole-cell reactivity when tested by RIA (Fig. 5, bars 7 to 10 ). This result is not surprising. Like the carboxy termini of a number of streptococcal surface proteins, the carboxy terminus of P1 is believed to be involved in anchoring the protein to the cell surface; therefore, it would be expected to be less accessible to the external environment than other regions of the molecule. Some subtle variation of reactivity of three of these antibodies with the four S. mutans serotype c isolates tested by RIA was observed (Fig. 5, P1 in conjunction with another surface molecule. 1-6F6b was the only one of the eleven anti-Pl MAbs generated by using intact bacterial cells as the immunogen. All others were generated by using mutanolysin-digested cell walls as the immunogen (3). All 11 anti-Pi MAbs tested demonstrated Western blot and RIA reactivity profiles that were virtually indistinguishable among S. mutans serotype c, e, and f strains. Only the anti-A. actinomycetemcomitans negative control MAb differentiated between these proteins in that it cross-reacted with the product of OMZ175 (serotype f). The predicted amino acid sequences of the P1 and PAc (serotype c) and SR (serotype f) proteins are 88% homologous (43) . Although the gene encoding the P1 molecule from a serotype e strain has not been cloned and sequenced, one would predict a high degree of amino acid homology with both the serotype c and f proteins on the basis of MAb reactivity. The reason why we found the product of the serotype f strain OMZ175 to have an Mr of 185,000 rather than 74,000 as described by other researchers (2) is unknown. Perhaps a polymorphism between the strains used in the two laboratories exists. The 74,000-Mr SR molecule is believed to result from posttranslational processing of a larger molecule, as the recombinant product of the cloned sr gene is reported to have an Mr of 195,000 (43, 54) .
Significant homology at the amino acid level between P1 (MSL-1 and PAc), SSP-5, and SpaA (PAg) also has been reported (12, 13, 32, 56) . Because SSP-5 and SpaA show some differences in their anti-Pl cross-reactivities, careful scrutiny of alignments of predicted amino acid sequences of these proteins with anti-Pl MAb reactivity profiles may enable finer epitope mapping to be accomplished. This will be feasible once the approximate binding sites of the MAbs are narrowed further. Construction of subclones of spaP which express defined truncated polypeptides and deletion mutagenesis approaches are under way in our laboratory and will allow those types of experiments to be done.
In addition to providing useful tools for analysis of immunological similarities and differences among the surface adhesin molecules of mutans streptococci, characterization of these MAbs is very important from the standpoint of being able to use them to answer questions regarding the structure and function of P1. To this end, experiments in our laboratory have been performed to analyze the ability of these MAbs to inhibit adherence of intact bacteria to salivary agglutinin-coated hydroxyapatite beads and to inhibit agglutinin-mediated aggregation of bacteria (7a) . Comparison of the results of all experiments performed to date with this panel of anti-Pl MAbs indicates that they can all be differentiated from one another. Therefore, 11 MAbs demonstrating unique specificities are available to further our understanding of P1 and related molecules at the molecular level.
